Losartan Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Source (Contract Manufacturing Organizations, In-House), By Form (Tablet, Powder), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By Region and Competition

Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Losartan Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Source (Contract Manufacturing Organizations, In-House), By Form (Tablet, Powder), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By Region and Competition

Forecast Period2024-2028
Market Size (2022)USD 1.64 Billion
CAGR (2023-2028)4.89%
Fastest Growing SegmentContract Manufacturing Organizations
Largest MarketNorth America
MIR Pharmaceuticals

Market Overview

Key Market Drivers

Growing Prevalence of Hypertension

Rising Geriatric Population

MIR Segment1

Increasing Clinical Efficacy

Patent Expiration and Generic Competition

Key Market Challenges

Side Effects and Tolerability

MIR Regional

Alternative Medications

Key Market Trends

Telehealth and Remote Monitoring

Personalized Medicine

Segmental Insights

Form Insights

Based on the form, the market is segmented into tablet and powder. The demand for Losartan in tablet form is higher than that for other forms, such as powder. Tablets are easy to handle and swallow, making them a convenient choice for most patients, including the elderly and those with swallowing difficulties. Tablets are pre-measured and provide a standardized dosage, ensuring accurate and consistent medication administration. Losartan tablets are typically packaged in blister packs or bottles, making it easy to store and transport them safely. Patients and healthcare providers are generally more familiar with tablet medications, which contributes to their popularity.

Application Insights

Based on the application segment, the market is segmented into hypertension, stroke, diabetic nephropathy, and others. The hypertension segment dominated the market as Losartan is primarily used for the treatment of hypertension, which is commonly known as high blood pressure. Hypertension is a widespread health issue, affecting a substantial portion of the global population. It is estimated that over one billion people worldwide have hypertension. This high prevalence ensures a consistent and substantial demand for antihypertensive medications like Losartan. In recent years, there has been a concerted effort to raise awareness about hypertension and promote regular blood pressure monitoring. As a result, more individuals are being diagnosed with high blood pressure, leading to an increased demand for effective treatments. Hypertension tends to become more prevalent with age. As the global population ages, a larger proportion of individuals are at risk of developing hypertension, further driving the demand for antihypertensive medications.

Regional Insights

Recent Developments

  • Granules India announced on February 2023 thatthe US Food and Drug Administration (US FDA) has approved its Abbreviated NewDrug Application (ANDA) for Losartan Potassium Tablets USP, available in 25 mg,50 mg, and 100 mg. Losartan Potassium is considered bioequivalent to thereference listed drug product (RLD), Cozaar Tablets by Organon LLC.
  • In April 2019, the FDA approved an expandedindication for losartan tablets to include treatment of high blood pressure inpediatric patients ages 6 years.

Key Market Players

  • Merck & Co. Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical IndustriesLtd.
  • Sanofi S.A.
  • Novartis International AG
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceuticals IndustriesLtd.
  • Aurobindo Pharma Ltd.
  • Torrent Pharmaceutical Ltd.
  • Lupin Ltd.

 By Source

By Form

By Application

By Region

 
  • Contract Manufacturing Organizations
  • In-House
  • Tablet
  • Powder
  • Hypertension
  • Stroke
  • Diabetic Nephropathy
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email